Neurofibromatosis Type I (Von Recklinghausen Disease): A Case Report and Review of the Literature

1. Peltonen S, Kallionpää RA, Peltonen J. Neurofibromatosis type 1 (NF1) gene: Beyond café au lait spots and dermal neurofibromas. Exp Dermatol 2017;26(7):645-648.10.1111/exd.1321227622733Search in Google Scholar

2. Boyd KP, Korf BR, Theos A. Neurofibromatosis type 1. J Am Acad Dermatol 2009; 61(1): 1-16.10.1016/j.jaad.2008.12.051271654619539839Search in Google Scholar

3. von Recklinghausen FD. Über die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen. Festschrift für Rudolf Virchow. Berlin, 1882.Search in Google Scholar

4. Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007;44(2):81-8.10.1136/jmg.2006.045906259806317105749Search in Google Scholar

5. Surchev JK, Nachev S, Todorova LP, et al. Optic Nerve Glioma in Two Sisters with Family History of Neurofibromatosis Type 1. J Neurol Surg A Cent Eur Neurosurg. 2018;79(3):268-272.10.1055/s-0037-160886929294511Search in Google Scholar

6. Vlenterie M, Flucke U, Hofbauer LC, et al. Pheochromocytoma and gastrointestinal stromal tumors in patients with neurofibromatosis type I. Am J Med. 2013;126(2):174-80.10.1016/j.amjmed.2012.07.02223331445Search in Google Scholar

7. Allaway RJ, Gosline SJ, La Rosa S, et al. Cutaneous neurofibromas in the genomics era: current understanding and open questions. Br J Cancer 2018;118(12):1539-1548.10.1038/s41416-018-0073-2600843929695767Search in Google Scholar

8. Packer RJ, Fisher MJ, Cutter G, et al. Neurofibromatosis Clinical Trial Consortium. J Child Neurol 2018;33(1):82-91.10.1177/088307381773919629246097Search in Google Scholar

9. Widemann BC, Acosta MT, Ammoun S, et al. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. Am J Med Genet A 2014; 164(3):563-78.10.1002/ajmg.a.36312415021224443315Search in Google Scholar

10. Walker JA, Upadhyaya M. Emerging therapeutic targets for neurofibromatosis type 1. Expert Opin Ther Targets 2018;22(5):419-437.10.1080/14728222.2018.1465931701775229667529Search in Google Scholar

11. Rad E, Tee AR. Neurofibromatosis type 1: Fundamental insights into cell signalling and cancer. Semin Cell Dev Biol 2016; 52:39-46.10.1016/j.semcdb.2016.02.00726860753Search in Google Scholar

12. Hanemann CO, Blakeley JO, Nunes FP, et al. Current status and recommendations for biomarkers and biobanking in neurofibromatosis. Neurology 2016;87(7 Suppl 1): S40-8.10.1212/WNL.0000000000002932557836027527649Search in Google Scholar